Screening of Tanzanian medicinal plants for anti-Candida activity

BMC Complementary and Alternative Medicine

Volumn 6, Issue , 2006, Pages

  Runyoro, Deborah K B ^a   Matee, Mecky I N ^a   Ngassapa, Olipa D ^a   Joseph, Cosam C ^b   Mbwambo, Zakaria H ^a  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b UNIVERSITY OF DAR ES SALAAM   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

ABRUS PRECATORIUS EXTRACT; ACACIA NILOTICA EXTRACT; AGATHISANTHEMUM BOJERI EXTRACT; ALBIZIA ANTHELMINTICA EXTRACT; ALLOPHYLLUS AFRICANUS EXTRACT; AMPHOTERICIN B; ANTIFUNGAL AGENT; ASPARAGUS AFRICANUS EXTRACT; BALANITES AEGYPTIACA EXTRACT; BONAMIA MOSSAMBICENSIS EXTRACT; BOSCIA SALICIFOLIA EXTRACT; BRIDELIA CATHARTICA EXTRACT; CARICA PAPAYA EXTRACT; CASSIA EXTRACT; CATUNAREGUM NILOTICA EXTRACT; CEIBA PENTANDRA EXTRACT; CHASSALIA UMBRATICOLA EXTRACT; CLUTIA ABYSSINICA EXTRACT; COMBRETUM MOLLE EXTRACT; DEINBOLLIA BORBONICA EXTRACT; EHRETIA AMOENA EXTRACT; ERIOSEMA PSORALEOIDES EXTRACT; HERBACEOUS AGENT; HIBISCUS MICRANTHUS EXTRACT; HOLARRHEMA FEBRIFUGA EXTRACT; LANNEA STUHLMANNII EXTRACT; PIGEONPEA EXTRACT; PLANT EXTRACT; PLECTRANTHUS BARBATUS EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AGAR MEDIUM; AGATHISANTHEMUM BOJERI; ALBIZIA ANTHELMINTICA; ALLOPHYLLUS AFRICANUS; ANTIFUNGAL ACTIVITY; ARTICLE; ASPARAGUS AFRICANUS; BALANITES AEGYPTIACA; BARK; BONAMIA MOSSAMBICENSIS; BOSCIA SALICIFOLIA; BRIDELIA CATHARTICA; CANDIDA ALBICANS; CATUNAREGUM NILOTICA; CEIBA PENTANDRA; CHASSALIA UMBRATICOLA; CLUTIA ABYSSINICA; COMBRETUM MOLLE; CONTROLLED STUDY; DEINBOLLIA BORBONICA; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG SCREENING; EHRETIA AMOENA; ERIOSEMA PSORALEOIDES; FUNGAL STRAIN; FUNGUS CULTURE; HIBISCUS MICRANTHUS; HOLARRHEMA FEBRIFUGA; INTERVIEW; LANNEA STUHLMANNII; MEDICINAL PLANT; NONHUMAN; PIGEONPEA; PLANT ROOT; PLECTRANTHUS BARBATUS; SOLVENT EXTRACTION; TANZANIA; TRADITIONAL MEDICINE;

ALBIZZIA; ANTIFUNGAL AGENTS; BALANITES; CANDIDA ALBICANS; MICROBIAL SENSITIVITY TESTS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT ROOTS; PLECTRANTHUS; TANZANIA;

EID: 33745304368     PISSN: 14726882     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-6-11     Document Type: Article

References (43)

1. Ghannoum MA: Future of antimycotic therapy. Dermatologic Therapy 1997, 3:104-11.
2. Vazquez JA:. Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients. HIV Clin Trials 2000, 1:47-59.
3. Vazquez JA: Options for the management of mucosal candidiasis in patients with AIDS and HIV infection. Pharmacotherapy 1999, 19:76-87.
4. Anteyi KO, Thacher TD, Yahanna S, Idoko JI: Oral manifestations of HIV-AIDS in Nigerian patients. Int J STD AIDS 2003, 14:395-8.
5. Edwards JE Jr: Candida species. In Mandell, Douglas and Bennett's principles and practice of infectious diseases Volume 2. 4th edition. Edited by: Mandell GL, Bennett JE, Dolin R. New York: Churchill Livingstone; 1995:2289-2301.
6. Krcmery V, Barnes AJ: Non-albicans Candida species causing fungaemia: Pathogenicity and antifungal resistance. J Hosp Infect 2002, 50:243-60.
7. Musial CE, Cockenii FR, Roberts GD: Fungal infections of the immunocompromised host. Clinical laboratory aspects. Clin Microbiol Rev 1988, 1:349-364.
8. Marty F, Mylonakis E: Antifungal use in HIV infection. Expert Opin Pharmacother 2002, 3:91-102.
9. UNAIDS: Report an the Global AIDS epidemic. UNAIDS 2004.
10. Mehta DK, Martin J, Jordan B, Macfarlane CR, Hashimi FT, Kouimtzi M, Ryan RSM, Shing T, Wagle SMS, Gallagher GP, (eds): British National Formulary 43rd edition. London, Pharmaceutical Press; 2002:294-298.
11. Feldmesser M: New and emerging antifungal agents: Impact on respiratory infections. Am J Respir Med 2003, 2:371-83.
12. Wong-Beringer A, Kriengkauykiat J: Systemic antifungal therapy: New options, new challenges. Pharmacotherapy 2003, 23:1441-62.
13. Perea S, López-Ribot JL, Kirkpatrick WR, McAtee RK, Santillán RA, Martínez M, Calabrese D, Sanglard D, Patterson TF: Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains, displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2001, 45:2676-2684.
14. Klepser ME: Antifungal resistance among Candida species. Pharmacotherapy 2001, 21:124S-132S.
15. Pelletier R, Loranger L, Marcote H, De Carolis E: Variconazole and fluconazole susceptibility of Candida isolates. J Med Microbiol 2002, 51:479-83.
16. Khan ZU, Chandy R, Metwali KE: Candida albicans strain carriage in patients and nursing staff of an intensive care unit: A study of morphotypes and resistotypes. Mycoses 2003, 46:476-86.
17. Debruyne D: Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses. an Pharmacokinet 1997, 33:52-77.
18. Lachoria L, Jain PC, Agrawal SC: Activity of some plant extracts against dermatophytes. Hindustan Antibiot Bull 1999, 41:17-21.
19. Rahalison L, Hamburger M, Hostettmann K. Monod M, Frenk E: A bioautographic agar overlay method for the detection of anti-fungal compounds from higher plants. Phytochem Anal 1991, 2:199-203.
20. Sawhney AN, Khan MR, Ndaalio G, Nkunya MHH, Wever SH: Studies on the rationale of African Traditional medicine. Part III. Preliminary screening of medicinal plants for antifungal activity. Pak J Sci Ind Res 1978, 21:193-196.
21. Khan MN, Ngassapa O, Matee MIN: Antimicrobial activity of Tanzanian chewing sticks against oral pathogenic microbes. Pharmaceutical Biol 2000, 38:235-240.
22. Laskaris G, Hadjivassiliou M, Stratigos J: Oral signs and symptoms in 160 Greek HIV-infected patients. J Oral Path Med 1992, 21:120-3.
23. Connolly GM, Hawkins D, Harcourt-Webster JN, Parsons PA, Husain OA, Gazzard BG: Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome. BMJ 1989, 30:1033-1039.
24. Namkinga LA, Matee MIN, Kivaisi AK, Moshiro C: Prevalence and risk factors for vaginal candidiasis among women seeking primary care for genital infections in Dar es Salaam, Tanzania. E Afr Med J 2005, 82:138-143.
25. Evans WC: Trease and Evans' Pharmacognosy Thirteenth edition. Bailliere Tindall, London, Philadelphia, Toronto, Marrickville, Tokyo; 1989.
26. Gundidza M: Screening of extracts from Zimbabwean higher plants II: Antifungal properties. Fitoterapia 1986, 57:111-113.
27. Boily Y, Van Puyvelde L: Screening of medicinal plants of Rwanda (Central Africa) for antimicrobial activity. J Ethnopharmacol 1986, 16:1-13.
28. Almagboul AZ, Bashir AK, Karim A, Salih M, Farouk A, Khalid SA: Antimicrobial activity of certain Sudanese plants used in folkloric medicine. Screening for antifungal activity (VI). Fitoterapia 1988, 59:393-396.
29. Taniguchi M, Chapya A. Kubo I, Nakanishi K: Screening of East African plants for antimicrobial activity. Chem Pharm Bull 1978, 26:2910-2913.
30. Desta B: Ethiopian traditional herbal drugs. Part II: Antimicrobial activity of 63 medicinal plants. J of Ethnopharmacol 1993, 39:129-139.
31. Al-Bagieh NH, Idowu A, Salako. NO: Effect of aqueous extract of miswak on the in vitro growth of Candida albicans. Microbios 1994, 80:107-113.
32. Saeed A. Ibrahim N, Bashand YS, El-Gengaihi S: Saponins of Bolanites aegyptiaca Del fruits and biological evaluation. Bull Fac Pharm Cairo Univ 1995, 33:105-109.
33. Fabry W, Okemo P, Ansorg R: Fungistatic and fungicidal activity of East African medicinal plants. Mycoses 1996, 39:67-70.
34. Dhawan BN, Patnaik GK, Rastogi RP, Singh KK, Tandon JS: Screening of Indian plants for biological activity. VI. Indian J Exp Biol 1977, 15:208-219.
35. Abreu PM, Martins ES, Kayser O, Bindseil KU, Siems K, Seemann A, Frevert J: Antimicrobial, antitumor and antileishmania screening of medicinal plants from Guinea-Bissau.- Phytomedicine 1999, 6:187-195.
36. Carpani G, Orsini F, Sisti M, Verrota L: Soponins from Albizia anthelmintica. Phytochemistry 1989, 28:863-866.
37. Tschesche R, Kammerer FJ: On triterpenes XXVII. The structure of musennin and deglucomusennin. (Über Triterpene XXVII Die strukturvon musennin und desglucomusennin). Justus Liebigs Ann Chem 1969, 724:183-193.
38. Farid H, Haslinger E, Kunert O, Wegner C, Hamburger M: New steroidal glycosides from Balanites aegyptiaca. Helv Chim Acta 2002, 85:1019-1026.
39. Wagner H, Bladt S, Zygainski EM: Plant Drug Analysis. A thin Layer Chromatography Atlas Springer Verlag, Berlin, Heidelberg, New York, Tokyo; 1984.
40. Gaudin O, Vacherat R: Rotenone and the ichthyotoxic power in some plants of the French Sudan. Bull Sci Pharmacol 1938, 45:385-394.
41. Mazzanti G, Erspamer GF, Mugne Y, Piccinelli D: Occurrence of Histamine and related imidazole compounds in extracts from root and trunk bark of Albizia adianthifolia, Albizia anthelmintica and Albizia julibrissin. Fitoterapia 1983, 54:275-280.
42. Abdel-Mogib M, Albar HA, Battrjee SM: Review. Chemistry of the Genus Plectranthus. Molecules 2002, 7:271-301.
43. Camara CC, Nascimento NR, Macedo-Filho CL, Almeida FB, Fonteles MC: Antispasmodic effect of the essential oil of Plectranthus barbatus and some major constituents on the guinea pig ileum. Planta Medica 2003, 69:1080-1085.